IB Geography F.5.3 Stakeholder Perspectives on Health and Food Security Notes

Stakeholder Priorities Reflect Different Benefits, Costs and Powers

1. A stakeholder supports a policy when its expected benefits, costs, values and risks align with the stakeholder's interests.
2. Farmers, firms, patients, ministries, donors and households may agree on the problem while preferring different solutions.
3. Power matters because some actors control budgets, law, technology or market access while others mainly experience the outcome.
4. Time horizon matters because a prevention programme may save future costs while a hospital treats visible illness now.
5. Spatial position matters because an intervention can benefit consumers while shifting risk to producers or another country.
6. Evaluation should identify who gains, who pays, who decides and whose evidence counts.

GM Crops Divide Stakeholders over Output, Control and Market Risk

1. Biotechnology firms gain revenue and influence through patented seed, licensing and linked input packages.
2. Governments may value higher or more stable yields, micronutrient gains and reduced pesticide use.
3. Smallholders may gain a useful trait but face seed cost, contractual dependence and loss of seed-saving practices.
4. Commercial farmers may value standardised performance while carrying the risk that export buyers reject the crop.
5. Consumers may value lower prices or added nutrients but demand safety assessment, labelling and choice.
6. Environmental groups may focus on gene flow, resistance and crop diversity rather than short-term yield.
7. The central disagreement concerns who controls the technology and absorbs its long-term risk, not only whether the crop grows.

Prevention and Treatment Compete for Budgets and Visibility

1. A finance ministry may support prevention when evidence suggests that avoided illness will reduce future expenditure.
2. A health minister may prefer hospitals or medicines because their benefits are immediate, visible and politically attributable.
3. Clinicians may prioritise treatment because they face patients whose needs cannot be postponed.
4. Public-health agencies may prioritise population measures that reduce incidence before patients arrive.
5. Marginalised groups may distrust both strategies when services have previously excluded or punished them.
6. Industry may oppose taxes or regulation that prevent disease by reducing sales of harmful products.
7. The most defensible allocation protects urgent patients while preserving prevention that reduces the future caseload.

Pandemic Vaccine Supply Exposes National and Global Priorities

1. High-income governments may purchase doses directly to protect their own populations and reduce domestic political risk.
2. Manufacturers seek predictable contracts, regulatory approval and returns on research and production investment.
3. COVAX and international agencies seek pooled procurement and equitable allocation across countries.
4. Lower-income governments need affordable supply, delivery finance and cold-chain support rather than promises alone.
5. Health workers and high-risk groups benefit when allocation follows exposure and clinical need rather than purchasing power.
6. Direct pre-purchase can accelerate national access while reducing the early supply available to a pooled mechanism.
7. Equity therefore requires production capacity and delivery commitments as well as an allocation rule.

Famine Declarations Affect Legitimacy, Access and Funding

1. Affected households need early assistance and may gain little from a technically precise label that arrives after assets have been sold.
2. Governments may fear that acknowledging famine signals failure, weakens legitimacy or invites external scrutiny.
3. Humanitarian agencies may need a formal classification to mobilise donor attention and justify exceptional action.
4. Donors seek evidence and accountability but may release funds only after a crisis becomes highly visible.
5. Armed groups may restrict access or manipulate aid to control territory and populations.
6. Waiting for a famine declaration can therefore satisfy evidential demands while allowing preventable deterioration.

A Stakeholder Matrix Makes the Judgement Explicit

1. List each stakeholder and record the main benefit, cost, risk, time horizon and degree of influence.
2. Separate direct effects, such as paying for seed, from indirect effects, such as later resistance or lost market access.
3. Identify conflicts between national totals and distribution, because aggregate gains can coexist with local losses.
4. Check whether compensation reaches the actor carrying the cost.
5. State which priority should lead and which safeguard is required for the least powerful group.
6. A defensible conclusion follows evidence and stated values rather than treating every perspective as equally effective.